Rockwell Medical (RMTI) FCF Margin Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | 1,848.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,848.00 |
| Mar 31, 2026 | 1,684.00 |
| Dec 31, 2025 | 1,383.00 |
| Sep 30, 2025 | -445.00 |
| Jun 30, 2025 | 4,260.00 |
| Mar 31, 2025 | 4,226.00 |
| Dec 31, 2024 | 6,152.00 |
| Sep 30, 2024 | 5,947.00 |
| Jun 30, 2024 | 3,870.00 |
| Mar 31, 2024 | 6,989.00 |
| Dec 31, 2023 | 5,662.00 |
| Sep 30, 2023 | 2,083.00 |
| Jun 30, 2023 | 5,093.00 |
| Mar 31, 2023 | 2,207.00 |
| Dec 31, 2022 | 3,308.00 |
| Sep 30, 2022 | 3,555.00 |
| Jun 30, 2022 | 3,911.00 |
| Mar 31, 2022 | -2,539.00 |
| Dec 31, 2021 | -2,438.00 |
| Sep 30, 2021 | -1,489.00 |